Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012452 |
---|---|
Receipt number | R000014567 |
Scientific Title | Phase II Trial of Pertuzumab plus Trastuzumab plus Docetaxel for HER2-Positive Metastatic Breast Cancer that Progressed During Prior Trastuzumab Therapy |
Date of disclosure of the study information | 2013/12/02 |
Last modified on | 2018/12/04 00:49:32 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/01 18:45:10 | ||
2 | Update | 2015/01/15 02:26:25 | Last name of contact person Last name of contact person Division name Division name |
|
3 | Update | 2018/12/04 00:49:32 | Recruitment status |